The HIV reverse transcriptase inhibitor tenofovir induces cell cycle arrest in human cancer cells
✍ Scribed by Ansgar Brüning, Petra Burger, Andrea Gingelmaier, Ioannis Mylonas
- Book ID
- 113064552
- Publisher
- Springer US
- Year
- 2011
- Tongue
- English
- Weight
- 509 KB
- Volume
- 30
- Category
- Article
- ISSN
- 0167-6997
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Prostate cancer is the most commonly diagnosed neoplasm in men. LNCaP cells continue to possess many of the molecular characteristics of in situ prostate cancer. These cells lack ras mutations, and mitogen-activated protein kinase (MAPK) is not extensively phosphorylated in these cells. To determine
## Abstract Reverse transcriptase (RT) inhibitors are emerging as a novel class of anticancer differentiating agents, active in several human tumor cell models, such as melanoma and prostate, thyroid and colon carcinoma. Indeed, much evidence suggests that they may act by inhibiting endogenous RT,